Submission Details
| 510(k) Number | K221178 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 25, 2022 |
| Decision Date | November 17, 2022 |
| Days to Decision | 206 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K221178 is an FDA 510(k) clearance for the Disposable Insulin Pen Needle, a Needle, Hypodermic, Single Lumen (Class II — Special Controls, product code FMI), submitted by Ningbo Medsun Medical Co., Ltd. (Ningbo, CN). The FDA issued a Cleared decision on November 17, 2022, 206 days after receiving the submission on April 25, 2022. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5570.
| 510(k) Number | K221178 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 25, 2022 |
| Decision Date | November 17, 2022 |
| Days to Decision | 206 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | FMI — Needle, Hypodermic, Single Lumen |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5570 |